Abstract:Mesoporous silica nanoparticles (MSNs) have shown incredible potential for drug delivery owing to their orderly mesoporous structure, high surface area, pore volume, and biocompatibility. pH-responsive MSN-based drug delivery systems may be used to deliver anticancer agents. This manuscript reports MSNs exclusively for pH-based drug delivery for controlled delivery applications. This study reports the development of positively charged MSNs under acidic conditions using a "modified sol–gel method." The developed MSNs were loaded with doxorubicin, a positively charged anticancer drug, lidocaine, a neutral topical anesthetic, and indomethacin, a negatively charged anti-inflammatory drug, by adsorption method. ATR-FT-IR spectra and XRD patterns of the neat MSNs and drug-loaded MSNs were obtained to study their physicochemical nature. SEM and TEM images showed the hexagonal arrangement of the neat MSNs and the changes observed after drug loading. The pH-responsive behavior of the MSNs loaded with the drugs was also characterized. From the results, we observed that the MSNs could be triggered to release the drugs by the pH of the solution and, therefore, could be a potential candidate for pH-based drug delivery systems. In vitro cytotoxicity assays were performed to study the anticancer activity of DOX-loaded MSNs. These in vitro studies were performed using three cancer cell lines, viz., MG-63 osteosarcoma cells, MCF-7 breast cancer cells, and MDA-MB-231 breast cancer cells. These assays showed effective inhibitory activity of the DOX-loaded MSNs. Furthermore, we have applied mathematical modeling to investigate the release of DOX from the pH-responsive MSNs in different pH environments. From the obtained modeling results, the sustained release of DOX from the non-functionalized MSNs fits well with the saturation kinetics model. Therefore, these positively charged MSNs synthesized by the modified sol–gel method can be potentially used for cancer therapy.

Acid-responsive intracellular doxorubicin release from click chemistry functionalized mesoporous silica nanoparticles

Stimuli-responsive Functionalized Mesoporous Silica Nanoparticles for Drug Release in Response to Various Biological Stimuli

Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles

Fabrication of a pH/Redox-Triggered Mesoporous Silica-Based Nanoparticle with Microfluidics for Anticancer Drugs Doxorubicin and Paclitaxel Codelivery

In Situ Monitoring of Intracellular Controlled Drug Release from Mesoporous Silica Nanoparticles Coated with Ph-Responsive Charge-Reversal Polymer

pH-controlled delivery of doxorubicin to cancer cells, based on small mesoporous carbon nanospheres.

Cytochrome C Capped Mesoporous Silica Nanocarriers for Ph-Sensitive and Sustained Drug Release

Ph-Responsive Nanoreservoirs Based on Hyaluronic Acid End-Capped Mesoporous Silica Nanoparticles for Targeted Drug Delivery.

Real-time cell analysis of the cytotoxicity of a pH-responsive drug-delivery matrix based on mesoporous silica materials functionalized with ferrocenecarboxylic acid.

A Surface-Grafted Ligand Functionalization Strategy for Coordinate Binding of Doxorubicin at Surface of PEGylated Mesoporous Silica Nanoparticles: Toward Ph-Responsive Drug Delivery

Facile Synthesis of Ph Sensitive Polymer-Coated Mesoporous Silica Nanoparticles and Their Application in Drug Delivery

pH-responsive drug release from positively charged mesoporous silica nanoparticles and their potential for anticancer drug delivery

Multifunctional Hybrid Silica Nanoparticles for Controlled Doxorubicin Loading and Release with Thermal and Ph Dual Response

Preparation of pH-Responsive Mesoporous Silica Nanoparticles and Their Application in Controlled Drug Delivery

Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.

pH responsive mesoporous silica as a carrier for controlling doxorubicin hydrochloride delivery

A Multifunctional Mesoporous Silica Nanocomposite for Targeted Delivery, Controlled Release of Doxorubicin and Bioimaging.

Enzyme-/Redox-Responsive Mesoporous Silica Nanoparticles Based on Functionalized Dopamine As Nanocarriers for Cancer Therapy

A Preloaded Amorphous Calcium Carbonate/Doxorubicin@Silica Nanoreactor for Ph‐responsive Delivery of an Anticancer Drug

Amidoxime functionalized mesoporous silica nanoparticles for pH-responsive delivery of anticancer drug

Ph- and Redox-Triggered Synergistic Controlled Release of a ZnO-gated Hollow Mesoporous Silica Drug Delivery System.